Date of Award
2017
Document Type
Dissertation/Thesis
Submission Date
October 2026
Thesis/Dissertation Advisor [Chair]
Maldonado, Monica
Abstract
Heterozygous mutations in PTEN are known to cause features of head overgrowth (macrocephaly) and autism spectrum disorder (ASD). PTEN is a lipid phosphatase that functions as a negative regulator of the PI3K-AKT-mTOR cell signaling pathway, which is crucial to cell growth and proliferation. In this study, we utilized a transgenic mouse model of macrocephaly/autism syndrome (Pten haploinsufficient mice) to generate cultures of primary neurons that display structural defects (e.g. neurite overgrowth and cell soma size) as compared to neurons derived from wild-type animals. We hypothesize that restoration of Pten levels in neurons derived from Pten haploinsufficient mice will restore normal functioning of the PI3K-AKT-mTOR signaling pathway, which in turn will reverse the morphological abnormalities seen in these cells. Our results indicate that adding a cell penetrating isoform of PTEN to haploinsufficient primary cortical neurons resulted in a rescue of the increased primary branching that is seen in Pten haploinsufficient cultures.
Recommended Citation
Walters, Vanessa Marie, "PROTEIN REPLACEMENT THERAPY TO TREAT NEURONAL STRUCTURAL DEFECTS CAUSED BY MUTATION OF THE AUTISM RISK GENE PTEN" (2017). Harriet L Wilkes Honors College Theses 2010 - 2019. 284.
https://digitalcommons.fau.edu/etd_honors_2/284
Extent
32 p.
Identifier
FA00012647
Comments
Includes bibliography.